Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel P Cahill

Showing results (191-200 of 196) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 196 results.
Nature|June 3, 2026
Acquired genetic and cell-state changes in IDH-mutant glioma progressionKevin C Johnson, Avishay Spitzer, Frederick S Varn, et al.
The Lancet. Oncology|November 27, 2025
A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect groupPhilipp Karschnia, Jacob S Young, Maarten M J Wijnenga, et al.
Nature Medicine|July 11, 2018
Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarateLukas Bunse, Stefan Pusch, Theresa Bunse, et al.
Cancer Cell|August 19, 2022
De novo pyrimidine synthesis is a targetable vulnerability in IDH mutant gliomaDiana D Shi, Milan R Savani, Michael M Levitt, et al.
Cell|July 23, 2019
An Integrative Model of Cellular States, Plasticity, and Genetics for GlioblastomaCyril Neftel, Julie Laffy, Mariella G Filbin, et al.
Nature|March 9, 2007
Patterns of somatic mutation in human cancer genomesChristopher Greenman, Philip Stephens, Raffaella Smith, et al.
Pageof 20

Showing results (191-200 of 196) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 196 results.
Nature|June 3, 2026
Acquired genetic and cell-state changes in IDH-mutant glioma progressionKevin C Johnson, Avishay Spitzer, Frederick S Varn, et al.
The Lancet. Oncology|November 27, 2025
A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect groupPhilipp Karschnia, Jacob S Young, Maarten M J Wijnenga, et al.
Nature Medicine|July 11, 2018
Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarateLukas Bunse, Stefan Pusch, Theresa Bunse, et al.
Cancer Cell|August 19, 2022
De novo pyrimidine synthesis is a targetable vulnerability in IDH mutant gliomaDiana D Shi, Milan R Savani, Michael M Levitt, et al.
Cell|July 23, 2019
An Integrative Model of Cellular States, Plasticity, and Genetics for GlioblastomaCyril Neftel, Julie Laffy, Mariella G Filbin, et al.
Nature|March 9, 2007
Patterns of somatic mutation in human cancer genomesChristopher Greenman, Philip Stephens, Raffaella Smith, et al.
Pageof 20